| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wang Kang-Huai | President and Chief Executive Officer Exhibit 24 - Power of Attorney, Director | C/O CAPSOVISION, INC., 18805 COX AVENUE, SUITE 250, SARATOGA | /s/ Tai Vivatvaraphol, Attorney-in-Fact for Kang-Huai Wang | 01 Jul 2025 | 0002075513 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CV | Common Stock | 915,207 | 01 Jul 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CV | Series A Preferred Stock | 01 Jul 2025 | Common Stock | 1,407,407 | Direct | F2 | |||||||
| holding | CV | Series C-1 Preferred Stock | 01 Jul 2025 | Common Stock | 33,707 | Direct | F2 | |||||||
| holding | CV | Series D Preferred Stock | 01 Jul 2025 | Common Stock | 11,111 | Direct | F2 | |||||||
| holding | CV | Series H Preferred Stock | 01 Jul 2025 | Common Stock | 35,947 | Direct | F2 | |||||||
| holding | CV | Stock Option (right to buy) | 01 Jul 2025 | Common Stock | 3,334 | $0.1100 | Direct | F3, F4 | ||||||
| holding | CV | Stock Option (right to buy) | 01 Jul 2025 | Common Stock | 11,459 | $0.1100 | Direct | F4, F5 | ||||||
| holding | CV | Stock Option (right to buy) | 01 Jul 2025 | Common Stock | 887,500 | $0.1700 | Direct | F4, F6 |
| Id | Content |
|---|---|
| F1 | Does not reflect a one-for-3.33 reverse stock split, to be effective immediately prior to the closing to the Issuer's initial public offering. |
| F2 | Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock (the "Preferred Stock") is convertible on a one-to-one basis into the underlying shares of common stock at the holder's election and has no expiration date. The Preferred Stock will automatically convert into common stock upon the closing of the Issuer's initial public offering. The number of underlying shares of common stock reported in Column 3 does not reflect a one-for-3.33 reverse stock split, to be effective immediately prior to the closing to the Issuer's initial public offering. |
| F3 | The derivative security is fully vested as to the original number of underlying shares of common stock, which was 80,000 shares. Prior to July 1, 2025, the reporting person partially exercised the stock option and purchased 76,666 of the underlying shares which had vested. |
| F4 | The number of underlying shares of common stock reported in Column 3 and the exercise price reported in Column 4 do not reflect a one-for-3.33 reverse stock split, to be effective immediately prior to the closing to the Issuer's initial public offering. |
| F5 | The options vested as to 25% of the original number of underlying shares of common stock, which was 50,000 shares, on April 1, 2023 and as to the remaining 75% of the shares in 36 equal monthly installments thereafter through April 1, 2026, subject to continued service to the Issuer on each such date. The options, to the extent then outstanding and unvested, will vest in full upon a change in control of the Issuer. Prior to July 1, 2025, the reporting person partially exercised the stock option and purchased 38,541 of the underlying shares which had vested. |
| F6 | The options vest as to 25% of the shares on November 1, 2025 and as to the remaining 75% of the shares in 36 equal monthly installments thereafter through November 1, 2028, subject to continued service to the Issuer on each such date. The options, to the extent then outstanding and unvested, will vest in full upon a change in control of the Issuer. |
President and Chief Executive Officer Exhibit 24 - Power of Attorney